We are a national coalition of AIDS activists, many living with HIV/AIDS,working together to end the AIDS epidemic by advancing research on HIV/AIDS

User: Password: Remember me: Forget Password?

Enter the email address of your account below to receive your password:

GlaxoSmithKline

Community Affairs Manager: Marc Meachem

Email: marc.s.meachem@gsk.com

Telephone Number: 919-483-8756

Approved Drugs:

1) Retrovir (zidovudine, AZT) - NRTI

2) Epivir (lamivudine, 3TC) - NRTI

3) Ziagen (abacavir) - NRTI

4) Combivir (zidovudine plus lamivudine) - Combination NRTI

5) Epzicom (abacavir plus lamivudine) - Combination NRTI

6) Trizivir (abacavir plus zidovudine plus lamivudine) - Combination NRTI

7) Lexiva (fosamprenavir) - PI

Drugs in Pre-approval Status:

1) GSK364735 - Integrase Inhibitor

Comment: - See data from CROI 2007 - moving into Phase IIb shortly

2) IDX-899 - NNRTI

Comment: a second generation NNRTI purchased recently from Idenix - see data from CROI 2008 - In Phase II studies

Patient Assistance Program:

Telephone: 866-GSK-FOR-U

Website: http://gskforyou.com/15_programs.htm

Co-Pay Assistance Program:

Telephone: 866-GSK-FOR-U

Website: http://www.mysupportcard.com/

 

Corporate website:  www.gsk.com